人兽共患病疫苗的发展

本文及以下诸稿均系生物制品学会预防制品学组一九九○年八月在兰州召开的学术讨论会上宣读的综述性论文,现刊出以供同仁参考。     

宠物源性人兽共患病

随着城市化进程的加快和人民生活水平的提高,城市中宠物的饲养数量急速上升,由此产生的一系列问题也逐步显现,尤其是与人类密切相关的＂卫生与健康＂问题,诸如狂犬病、弓形体病等＂人兽共患病＂引发的公共卫生安全问题已引起社会和国家各主管部门的高度关注。强化宠物源人兽共患病的防范意识,采取有效的措施控制此类人兽共患病的发生,具有十分重要的现实意义。     

湖南省实验动物中几种常见的人兽共患病监测

目的对2003年至2007年湖南省实验动物中沙门氏菌、汉坦病毒、仙台病毒、淋巴细胞脉络丛脑膜炎病毒、弓形虫病等几种常见的人兽共患病的流行病学进行调查。方法按《GB14922．2-2001》和《GB14922．1-2001》抽检动物。结果实验大、小鼠汉坦病毒（HV）和仙台病毒（Sendai）出现抗体阳性,实验小鼠淋巴细胞脉络丛脑膜炎病毒（LCM）出现抗体阳性,实验鼠沙门氏菌（Salmonella）检测结果阳性,实验大鼠和普通级兔弓形体（Toxoplasma）检测结果阳性。结论应加强对实验动物流行病学的监测。     

宠物重要人兽共患病毒病

随着人们生活水平的不断提高,城市家庭饲养宠物日益增多,宠物已经成为人们日常生活中接触最多的动物。然而,许多宠物是人兽共患疾病的重要传染源,随着人类与各种动物间＂零＂距离的接触,各种宠物携带的人兽共患病也悄然传入人类,给人们身体健康和公共卫生安全带来了严重的威胁。近年来,许多学者对犬、猫、鸟、鼠和其他宠物易感的人兽共患病毒病开展了许多研究工作,本文对狂犬病、戊型肝炎、禽流感、淋巴细胞脉络膜脑膜炎、流行性出血热、西尼罗热等一些严重危害的宠物人兽共患病毒病进行了概述。     

人兽共患真菌病的现状

人兽共患真菌病是由真菌引起的人和动物的感染性疾病。近年来的研究发现一些原本被认为是非致病或条件致病性的真菌,如曲霉、隐球菌、组织胞浆菌、马尔尼菲青霉等引起的人兽共患病不断增加,严重地威胁着人和动物的健康。本文主要介绍了皮肤、皮下组织及深部感染3类人兽共患真菌病的病原学及流行病学特征,以阐明预防、控制人兽共患病发生的重要意义。     

典型人兽共患病枚举

鼠疫鼠疫是鼠疫杆菌引起的一种烈性传染病,最先流行于鼠类及其他野生啮齿动物之间,借助鼠蚤叮咬而传染给人,也可以通过直接接触受感染的动物或被病兽咬伤而感染。病人死后皮肤会出现大片黑色瘀斑,因此又被人们称为"黑死病"。鼠疫通常有腺型、肺型和败血症型三种,病人发生肺部感染后,病原体可以借助飞沫传播。人类普遍易感,但病后可获得持久免疫。鼠疫传染性强、     

基因芯片技术检测重要人兽共患病病毒方法的建立

为了建立能对25种重要人兽共患病病毒进行筛查及鉴定用的基因芯片技术,本实验首先设计针对每种病毒的寡核苷酸探针并进行探针特异性的生物信息学验证.然后探索病毒核酸随机扩增方法,优化杂交动力学条件,建立本芯片标准的数据处理分析方法.最后用细胞培养的病毒和模拟临床标本验证芯片的敏感性与特异性．结果表明,锚定随机PCR扩增法适合于本芯片病毒核酸的扩增;芯片杂交前用0.25% NaBH4进行封闭,最优杂交条件为51 ℃,2 h及50%甲酰胺浓度;芯片具有较好的敏感性及检测特异性．初步结果表明,本实验所建立的基因芯片技术可应用于对25种重要人兽共患病病毒进行筛查及鉴定．     

预防人畜共患病必须确立"人病兽防"观点

人畜共患病(zoonosis)也称人兽共患病,是指脊椎动物与人类之间自然传播的疾病和感染疾病.它是由病毒、细菌、衣原体、立克次体、支原体、螺旋体、真菌、原虫和蠕虫等病原体所引起的各种疾病的总称.     

人兽共患病病原学专家——于恩庶

于恩庶,英文名Yu En-shu,1918年4月3日出生于辽宁省盖平县圣水村(今属大石桥市百寨镇),2011年1月13日卒于福州市。     

人兽共患病疫苗——“一体化健康”模式

<正>本综述着重于描述动物免疫作为预防人类疾病(人兽共患病)的一种方法。描述了所用疫苗的三种类型,所举例子有成功例子也有失败例子。Ⅰ类疫苗用于保护人和有经济价值的动物,这二者在病原体传播循环中都不起什么作用。讨论了开发Ⅰ类疫苗过程中,动物健康产业和人健康产业与管理机构之间合作的好处,描述了在动物和人中都能使用的疫苗的唯一例子(西尼罗病毒疫苗)。Ⅱ类疫苗是用于家养动物的疫苗,以免疫家养动物作为预防     

幽门螺杆菌空泡毒素研究进展

幽门螺杆菌空泡毒素是该菌产生的已知其它细菌毒素无明显源性的唯一蛋白毒素。该毒素是幽门螺杆菌重要的毒力致病因子,它的产生与感染胃肠上皮损伤和溃疡形成密切相关。本就幽门螺杆菌空泡毒素的结构与功能研究进展以及在未来免疫预防与免疫治疗中的作用进行了阐述。     

Non-Helicobacter pylori helicobacters detected in the stomach of humans comprise several naturally occurring Helicobacter species in animals

Besides the well-known gastric pathogen Helicobacter pylori , other Helicobacter species with a spiral morphology have been detected in a minority of human patients who have undergone gastroscopy. The very fastidious nature of these non- Helicobacter pylori helicobacters (NHPH) makes their in vitro isolation difficult. These organisms have been designated ' Helicobacter heilmannii '. However, sequencing of several genes detected in NHPH-infected tissues has shown that the ' H. heilmannii ' group comprises at least five different Helicobacter species, all of them known to colonize the stomach of animals. Recent investigations have indicated that Helicobacter suis is the most prevalent NHPH species in human. This species has only recently been isolated in vitro from porcine stomach mucosa. Other NHPH that colonize the human stomach are Helicobacter felis, Helicobacter bizzozeronii, Helicobacter salomonis and ' Candidatus Helicobacter heilmannii'. In numerous case reports of human gastric NHPH infections, no substantial information is available about the species status of the infecting strain, making it difficult to link the species with certain pathologies. This review aims to clarify the complex nomenclature of NHPH species associated with human gastric disease and their possible animal origin. It is proposed to use the term 'gastric NHPH' to designate gastric spirals that are morphologically different from H. pylori when no identification is available at the species level. Species designations should be reserved for those situations in which the species is defined.     

Genetic relationship among isolates of Helicobacter pylori: evidence for the existence of a Helicobacter pylori species-complex

We investigated the population genetics of 23 isolates of H. pylori by allozyme electrophoresis using 16 enzyme loci. Isolates were obtained from adult patients of whom 48% were of Greek extraction. Eight patients (35%) had an active duodenal ulcer. Allelic variation per loci ranged from 2 to 11 alleles. Four major genetic clusters were apparent, having >75% fixed genetic differences. There was no distinct clustering (clonal structure) on the basis of the geographical origin of the persons from whom isolates were obtained, indicating that this bacterium has not recently jumped a species barrier into humans. Isolates associated with ulcer disease were not monophyletic, with isolates from ulcer patients being found in phylogenetically diverse branches of the dendogram derived from the data. Based on the genetic diversity of H. pylori isolates, we propose that isolates should be classified as belonging not to a single species but to a `Helicobacter pylori species-complex'.     

Partial characterization of a cell-free hemolytic factor produced by Helicobacter pylori

Abstract Maximum cell-free hemolytic activity of Helicobacter pylori cultured in broth containing 10% horse serum occurred only after the stationary phase of growth was reached, unlike many hemolysins produced by Gram-negative bacteria which are active during exponential growth. This characteristic of the H. pylori hemolytic factor suggested that it might also possess protease activity. However, because no evidence of albumin degradation was found, the hemolysis by cell-free concentrates of H. pylori appears to be due to a unique factor derived from the organism. Because variable hemolysis results were obtained with culture broths lacking albumin or serum, these proteins may act as carriers or stabilizers of the putative hemolysin.     

High-affinity binding of laminin by Helicobacter pylori: Evidence for a lectin-like interaction

Abstract Laminin, the major glycoprotein of basement membranes, was shown to be bound by the human gastric pathogen Helicobacter pylori . Binding of ¹²⁵I-laminin by strain 17874 was time-dependent, specific and saturable. Scatchard analysis of specific binding indicated about 2000 binding sites per cell with a dissociation constant of 8.5 pM. Treatment of the cells by heat (80°) and with proteolytic enzymes drastically reduced laminin binding, suggesting that the laminin receptors are surface proteins. Some highly glycosylated glycoproteins inhibited laminin binding by 50%. Furthermore, N -acetylneuraminyllactose decreased laminin binding by 70% and neuraminidase treatment of laminin by 50%, while a recombinant B1 chain of laminin, containing high-mannose type oligosaccharides, inhibited binding by only 25%. This suggests that terminal sialic acids on laminin compete for a specific sugar binding protein(s) on H. pylori cells.     

Helicobacter pylori antibodies and gastric cancer: a gender-related difference

Helicobacter pylori has been proposed as a causative agent of gastric cancer. The aim of this study was to define serum antibodies response against different H. pylori antigens in patients with gastric cancer. Serum samples were collected from 115 Lithuanian patients with non-cardia gastric cancer and 110 age- and sex-matched controls without cancer. Heat-stable, low-molecular-mass, and outer membrane proteins were used as antigens to analyze serum IgG antibody response against H. pylori by enzyme-linked immunosorbent assay. Seroprevalence of H. pylori using low-molecular-mass antigen was significantly higher in gastric cancer patients, compared to controls (77% versus 57%, p<0.05). Significant differences in the prevalence of H. pylori infection between gastric cancer patients and controls were found in females using all three studied antigens: heat-stable (98% versus 84%, p<0.05), low-molecular-mass (88% versus 48%, p<0.05) and outer membrane proteins (78% versus 57%, p<0.05). In males, no significant differences were revealed between gastric cancer patients and controls. There may be other cofactors in addition to H. pylori that are important for the development of gastric cancer. H. pylori seems, however, to be a more important for development of gastric cancer in females than in males or males may have more confounding risk factors for gastric cancer than females.